Mission
ICAN’s mission is to assist and empower late-stage patients worldwide with cutting-edge information regarding anticancer drugs in clinical trials as well as physician referrals at the patient’s request based on the patient’s reported medical situation. ICAN takes the position that there are key decision points in the battle for life and without the best available information, the cancer patient will not be well-armed for the road ahead. ICAN assists the patient at such critical decision points in an effort to prolong life, taking into account quality of life and pain management issues. The ICAN patient finalizes all treatment choices with his/her medical team. Primacy is placed upon avoiding lost time and easing the transition between a patient’s last set of CT/MRI/PET/CT scans (as well as lab tests) and the entry into either a clinical trial or a more creative treatment regimen.
For more information please click here.